Clinical trial
A Placebo-controlled, Randomized, Phase 2a, Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of CIVI 007 in Patients on a Background of Stable Statin Therapy
NCT04164888 is registered in ClinicalTrials.gov with Civi Biopharma, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Placebo-controlled, Randomized, Phase 2a, Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of CIVI 007 in Patients on a Background of Stable Statin Therapy
- Lead sponsor
- Civi Biopharma, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 11, 2019
- Completion date
- November 17, 2020
- Enrollment
- 49 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.